Litcius/Paper detail

Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study

Daniela Bernardi, Giulia Vatteroni, Alessandra Acquaviva, Marvi Valentini, Vincenzo Sabatino, Isabella Bolengo, Marco Pellegrini, Carmine Fantò, Rubina Manuela Trimboli

2022American Journal of Roentgenology32 citationsDOI

Abstract

Although MRI remains the preferred test for NAT response monitoring, the findings support CEM as a useful alternative when MRI is contraindicated or not tolerated.

Topics & Concepts

MedicineBreast cancerNatMammographyBreast MRIRadiologyProspective cohort studyCancerNeoadjuvant therapyBiopsyMagnetic resonance imagingNuclear medicinePathologyInternal medicineComputer scienceComputer networkDigital Radiography and Breast ImagingBreast Cancer Treatment StudiesMedical Imaging Techniques and Applications
Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study | Litcius